These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

129 related articles for article (PubMed ID: 31836853)

  • 1. Role of AID in the temporal pattern of acquisition of driver mutations in multiple myeloma.
    Maura F; Rustad EH; Yellapantula V; Łuksza M; Hoyos D; Maclachlan KH; Diamond BT; Greenbaum BD; Morgan G; Lesokhin A; Papaemmanuil E; Landgren O
    Leukemia; 2020 May; 34(5):1476-1480. PubMed ID: 31836853
    [No Abstract]   [Full Text] [Related]  

  • 2. Genomic discovery and clonal tracking in multiple myeloma by cell-free DNA sequencing.
    Guo G; Raje NS; Seifer C; Kloeber J; Isenhart R; Ha G; Yee AJ; O'Donnell EK; Tai YT; Richardson PG; Bianchi G; Laubach JP; Warren D; Gemme E; Voisine J; Frede J; Kokkalis A; Yun H; Dimitrova V; Vijaykumar T; Meyerson M; Munshi NC; Anderson KC; Knoechel B; Lohr JG
    Leukemia; 2018 Aug; 32(8):1838-1841. PubMed ID: 29749395
    [No Abstract]   [Full Text] [Related]  

  • 3. Multiple myeloma clonal evolution in homogeneously treated patients.
    Corre J; Cleynen A; Robiou du Pont S; Buisson L; Bolli N; Attal M; Munshi N; Avet-Loiseau H
    Leukemia; 2018 Dec; 32(12):2636-2647. PubMed ID: 29895955
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The genetic architecture of multiple myeloma.
    Morgan GJ; Walker BA; Davies FE
    Nat Rev Cancer; 2012 Apr; 12(5):335-48. PubMed ID: 22495321
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Whole-genome sequencing reveals activation-induced cytidine deaminase signatures during indolent chronic lymphocytic leukaemia evolution.
    Kasar S; Kim J; Improgo R; Tiao G; Polak P; Haradhvala N; Lawrence MS; Kiezun A; Fernandes SM; Bahl S; Sougnez C; Gabriel S; Lander ES; Kim HT; Getz G; Brown JR
    Nat Commun; 2015 Dec; 6():8866. PubMed ID: 26638776
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Clonal hematopoiesis in patients with multiple myeloma undergoing autologous stem cell transplantation.
    Chitre S; Stölzel F; Cuthill K; Streetly M; Graham C; Dill C; Mohamedali A; Smith A; Schetelig J; Altmann H; Bornhäuser M; Mufti GJ
    Leukemia; 2018 Sep; 32(9):2020-2024. PubMed ID: 30026569
    [No Abstract]   [Full Text] [Related]  

  • 7. Accelerated single cell seeding in relapsed multiple myeloma.
    Landau HJ; Yellapantula V; Diamond BT; Rustad EH; Maclachlan KH; Gundem G; Medina-Martinez J; Ossa JA; Levine MF; Zhou Y; Kappagantula R; Baez P; Attiyeh M; Makohon-Moore A; Zhang L; Boyle EM; Ashby C; Blaney P; Patel M; Zhang Y; Dogan A; Chung DJ; Giralt S; Lahoud OB; Peled JU; Scordo M; Shah G; Hassoun H; Korde NS; Lesokhin AM; Lu S; Mailankody S; Shah U; Smith E; Hultcrantz ML; Ulaner GA; van Rhee F; Morgan GJ; Landgren O; Papaemmanuil E; Iacobuzio-Donahue C; Maura F
    Nat Commun; 2020 Jul; 11(1):3617. PubMed ID: 32680998
    [TBL] [Abstract][Full Text] [Related]  

  • 8. High subclonal fraction of 17p deletion is associated with poor prognosis in multiple myeloma.
    Thakurta A; Ortiz M; Blecua P; Towfic F; Corre J; Serbina NV; Flynt E; Yu Z; Yang Z; Palumbo A; Dimopoulos MA; Gutierrez NC; Goldschmidt H; Sonneveld P; Avet-Loiseau H
    Blood; 2019 Mar; 133(11):1217-1221. PubMed ID: 30692124
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Mutational processes contributing to the development of multiple myeloma.
    Hoang PH; Cornish AJ; Dobbins SE; Kaiser M; Houlston RS
    Blood Cancer J; 2019 Aug; 9(8):60. PubMed ID: 31387987
    [TBL] [Abstract][Full Text] [Related]  

  • 10.
    Boyle EM; Ashby C; Tytarenko RG; Deshpande S; Wang H; Wang Y; Rosenthal A; Sawyer J; Tian E; Flynt E; Hoering A; Johnson SK; Rutherford MW; Wardell CP; Bauer MA; Dumontet C; Facon T; Thanendrarajan S; Schinke CD; Zangari M; van Rhee F; Barlogie B; Cairns D; Jackson G; Thakurta A; Davies FE; Morgan GJ; Walker BA
    Clin Cancer Res; 2020 May; 26(10):2422-2432. PubMed ID: 31988198
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Genome-wide association study of monoclonal gammopathy of unknown significance (MGUS): comparison with multiple myeloma.
    Thomsen H; Chattopadhyay S; Weinhold N; Vodicka P; Vodickova L; Hoffmann P; Nöthen MM; Jöckel KH; Langer C; Hajek R; Hallmans G; Pettersson-Kymmer U; Ohlsson C; Späth F; Houlston R; Goldschmidt H; Hemminki K; Försti A
    Leukemia; 2019 Jul; 33(7):1817-1821. PubMed ID: 30737484
    [No Abstract]   [Full Text] [Related]  

  • 12. Timing the initiation of multiple myeloma.
    Rustad EH; Yellapantula V; Leongamornlert D; Bolli N; Ledergor G; Nadeu F; Angelopoulos N; Dawson KJ; Mitchell TJ; Osborne RJ; Ziccheddu B; Carniti C; Montefusco V; Corradini P; Anderson KC; Moreau P; Papaemmanuil E; Alexandrov LB; Puente XS; Campo E; Siebert R; Avet-Loiseau H; Landgren O; Munshi N; Campbell PJ; Maura F
    Nat Commun; 2020 Apr; 11(1):1917. PubMed ID: 32317634
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Exome sequencing in tracking clonal evolution in multiple myeloma following therapy.
    Weston-Bell N; Gibson J; John M; Ennis S; Pfeifer S; Cezard T; Ludwig H; Collins A; Zojer N; Sahota SS
    Leukemia; 2013 Apr; 27(5):1188-91. PubMed ID: 23147253
    [No Abstract]   [Full Text] [Related]  

  • 14. Clonal selection and double-hit events involving tumor suppressor genes underlie relapse in myeloma.
    Weinhold N; Ashby C; Rasche L; Chavan SS; Stein C; Stephens OW; Tytarenko R; Bauer MA; Meissner T; Deshpande S; Patel PH; Buzder T; Molnar G; Peterson EA; van Rhee F; Zangari M; Thanendrarajan S; Schinke C; Tian E; Epstein J; Barlogie B; Davies FE; Heuck CJ; Walker BA; Morgan GJ
    Blood; 2016 Sep; 128(13):1735-44. PubMed ID: 27516441
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Reconstructing the evolutionary history of multiple myeloma.
    Maura F; Rustad EH; Boyle EM; Morgan GJ
    Best Pract Res Clin Haematol; 2020 Mar; 33(1):101145. PubMed ID: 32139011
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Clonal Evolution in Multiple Myeloma.
    Fakhri B; Vij R
    Clin Lymphoma Myeloma Leuk; 2016 Aug; 16 Suppl():S130-4. PubMed ID: 27521309
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Stability and uniqueness of clonal immunoglobulin CDR3 sequences for MRD tracking in multiple myeloma.
    Rustad EH; Misund K; Bernard E; Coward E; Yellapantula VD; Hultcrantz M; Ho C; Kazandjian D; Korde N; Mailankody S; Keats JJ; Akhlaghi T; Viny AD; Mayman DJ; Carroll K; Patel M; Famulare CA; Op Bruinink DH; Hutt K; Jacobsen A; Huang Y; Miller JE; Maura F; Papaemmanuil E; Waage A; Arcila ME; Landgren O
    Am J Hematol; 2019 Dec; 94(12):1364-1373. PubMed ID: 31571261
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Hierarchy of mono- and biallelic
    Munawar U; Rasche L; Müller N; Vogt C; Da-Via M; Haertle L; Arampatzi P; Dietrich S; Roth M; Garitano-Trojaola A; Steinhardt MJ; Strifler S; Gallardo M; Martinez-Lopez J; Bargou RC; Heckel T; Einsele H; Stühmer T; Kortüm KM; Barrio S
    Blood; 2019 Sep; 134(10):836-840. PubMed ID: 31340981
    [No Abstract]   [Full Text] [Related]  

  • 19. Targeting the BRAF V600E mutation in multiple myeloma.
    Andrulis M; Lehners N; Capper D; Penzel R; Heining C; Huellein J; Zenz T; von Deimling A; Schirmacher P; Ho AD; Goldschmidt H; Neben K; Raab MS
    Cancer Discov; 2013 Aug; 3(8):862-9. PubMed ID: 23612012
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Myeloid transformation of plasma cell myeloma: molecular evidence of clonal evolution revealed by next generation sequencing.
    Gralewski JH; Post GR; van Rhee F; Yuan Y
    Diagn Pathol; 2018 Feb; 13(1):15. PubMed ID: 29463311
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.